| Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering - PR Newswire (press release) |
|
|
PR Newswire (press release) Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, |